Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
PALI
SABS
Add up to 3 more stocks
PALI
Palisade Bio, Inc.
+2.05%
$1.49+0.03Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$258.63M
52W Range
$1.32 - $2.86
SABS
SAB Biotherapeutics, Inc.
-5.48%
$2.93-0.17Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$266.59M
52W Range
$2.10 - $5.15
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.12 | 1.24 |
| P/S Ratio | 517.27 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | -6388.2% | 0.0% |
| ROE | -26.2% | -6.0% |
| ROA | -25.1% | -5.4% |
| ROIC | -29.0% | -31.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 24.26 | 9.22 |
| Quick Ratio | 24.26 | 9.22 |
| Debt/Equity | 0.00 | 0.02 |
| Interest Coverage | -1805.60 | -203.41 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.